The School for Policy Studies is excited to share the excellent improvement in subject ranking in the QS World University Subject Rankings, moving 15 places up to 18th in the world for Social Policy ...
A Crew Dragon spacecraft docked with the International Space Station on Valentine’s Day, and astronauts popped open the hatches at 5:14 pm ET (22:14 UTC) on Saturday evening. The arrival of four new ...
Agriculture and food security minister Mohamad Sabu said the variety of resources would help minimise risks of supply disruption and benefit the development of the agrofood industry without ...
The Philadelphia Phillies are in the market for outfield help this offseason. Harrison Bader is a free agent, and Nick Castellanos is very likely to be traded or cut this winter. While Brandon Marsh ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — Novo Nordisk’s new CEO dismissed on Wednesday that his company’s ...
Complement 3 glomerulopathy (C3G) is a rare kidney disease that affects your body’s innate immune system (complement system). Complement 3 glomerulopathy (C3G) is a kidney disease that’s caused by ...
A research team at the Medical University of South Carolina reports in Cells that the complement system, part of the body's natural immune defenses, is a key driver of inflammatory responses that ...
WEST LAFAYETTE, Ind. — The U.S. Department of Agriculture has selected Indianapolis as one of five hub locations to relocate the agency’s staff and other resources from the Washington, D.C., area. The ...
In myasthenia gravis, complement plays a big role in what happens to the muscle end of the neuromuscular junction, explains Miriam Freimer, MD, an author on 5 abstracts presented at the recent 15th ...
SAN FRANCISCO and SUZHOU, China, May 7, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes ...
MONTREAL, April 30, 2025 /CNW/ - The CHU Sainte-Justine and the CQDM are proud to announce the creation of the Centre d'expertise sur les maladies rares médiées par le complément (here after the ...
A substantial proportion of patients with CIDP are refractory to first-line treatments. New drugs tried in CIDP are first aimed at refractory patients. The use of complement-targeting therapies, such ...